Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Rigel Pharmaceuticals, Inc.”

373 pharma patents match "Rigel Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 373
Index total 30,257
Page 2 / 16

Quick answer

This filtered view shows 373 pharmaceutical patents matching "Rigel Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

373 results for “Rigel Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 11472782

    RIP1 inhibitory compounds and methods for making and using the same

    Rigel Pharmaceuticals, Inc. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted

  2. US 11466018

    TGF-β inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  3. US 11407736

    RIP1 inhibitory compounds and methods for making and using the same

    Rigel Pharmaceuticals, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

  4. US 11377428

    RIP1 inhibitory compounds and methods for making and using the same

    Rigel Pharmaceuticals, Inc. · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  5. US 11370764

    RIP1 inhibitory compounds and methods for making and using the same

    Rigel Pharmaceuticals, Inc. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  6. US 11370787

    Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulations

    Rigel Pharmaceuticals, Inc. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  7. US 11370808

    Pyrazole compounds and methods for making and using the compounds

    Rigel Pharmaceuticals, Inc. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  8. US 11370765

    RIP1 inhibitory compounds and methods for making and using the same

    Rigel Pharmaceuticals, Inc. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  9. US 11352360

    TGF-beta inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted

  10. US 11332451

    RIP1 inhibitory compounds and methods for making and using the same

    Rigel Pharmaceuticals, Inc. · Granted May 17, 2022 · Expires May 12, 2042

    granted

  11. US 11299486

    Benzazole compounds and methods for making and using the compounds

    Rigel Pharmaceuticals, Inc. · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  12. US 11279686

    Nrf2 activating compounds and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted

  13. US 11230554

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Jan 25, 2022 · Expires Jan 20, 2042

    granted

  14. US 11220496

    Compounds and method for treating autoimmune diseases

    Rigel Pharmaceuticals, Inc. · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted

  15. US 11198689

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  16. US 11174251

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted

  17. US 11174246

    Direct AMPK activators

    Rigel Pharmaceuticals, Inc. · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted

  18. US 11129819

    Fumarate analogs and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  19. US 11110082

    Tyrosine kinase inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted

  20. US 11104737

    ACVR2A-specific antibody and method of treatment of muscle atrophy

    Rigel Pharmaceuticals, Inc. · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted

  21. US 11059814

    Kinase inhibitors and methods for making and using

    Rigel Pharmaceuticals, Inc. · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted

  22. US 11021468

    TGF-ß inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jun 1, 2021 · Expires May 27, 2041

    granted

  23. US 11007193

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted

  24. US 10975064

    RIP1 inhibitory compounds and methods for making and using the same

    Rigel Pharmaceuticals, Inc. · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.